Climb Bio Inc: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges

The present stock price for Climb Bio Inc (CLYM) is $1.9. In the last trading session, the stock made a considerable jump, reaching $10.0 after an opening price of $1.9. The stock briefly fell to $7.0 before ending the session at $1.72.

Climb Bio Inc’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $8.79 on 09/16/24 and a low of $1.05 for the same time frame on 04/07/25.

52-week price history of CLYM Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Climb Bio Inc’s current trading price is -78.38% away from its 52-week high, while its distance from the 52-week low is 80.95%. The stock’s price range during the 52-week period has remained between $1.05 and $8.79. In the Healthcare sector, the company’s shares saw a trading volume of around 1.14 million for the day, which was evidently higher than the average daily volume of 0.37 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Climb Bio Inc (CLYM) has experienced a quarterly rise of 58.33% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 128.75M and boasts a workforce of 18 employees.

A Closer Look at Analysts’ Ratings for Climb Bio Inc

As of right now, 4 analysts are rating Climb Bio Inc as a BUY, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.3279, with a change in price of +0.5800. Similarly, Climb Bio Inc recorded 298,234 in trading volume during the last 100 days, posting a change of +43.94%.

CLYM Stock Stochastic Average

Climb Bio Inc’s raw stochastic average for the past 50 days is presently 96.02%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 94.62%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 74.40% and 63.21%, respectively.

CLYM Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. The index has shown a price loss of -69.45% this year. Over the last six months, there has been a weaker performance of 19.50%. The price of CLYM fallen by 30.14% during the last 30 days period. For the last 5-days stocks have improved 11.76%.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.